Email this article Effect of Vascular Endothelial Growth Factor and Erythropoietin on Functional Activity of Fibroblasts and Multipotent Mesenchymal Stromal Cells
- Authors: Bondarenko N.A.1,2, Nikonorova Y.V.1, Surovtseva M.A.1, Lykov A.P.1,2, Poveshchenko O.V.1,2, Poveshchenko A.F.1,2, Pokushalov E.A.2, Romanov A.B.2, Konenkov V.I.1,2
-
Affiliations:
- Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
- E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
- Issue: Vol 160, No 4 (2016)
- Pages: 498-501
- Section: Experimental Biology
- URL: https://journals.rcsi.science/0007-4888/article/view/236755
- DOI: https://doi.org/10.1007/s10517-016-3206-8
- ID: 236755
Cite item
Open Access
Access granted
Subscription Access
Abstract
The study examined the effect of VEGF and erythropoietin on proliferative and migratory activities of skin fibroblasts and multipotent mesenchymal stromal cells of human adipose tissue. VEGF stimulated proliferation and migration of fi broblasts, but produced no significant effect on functional activity of multipotent mesenchymal stem cells. Erythropoietin stimulated proliferation of both cell types, but did not affect their migration.
About the authors
N. A. Bondarenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Author for correspondence.
Email: bond802888@yandex.ru
Russian Federation, Moscow; Novosibirsk
Yu. V. Nikonorova
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Russian Federation, Moscow
M. A. Surovtseva
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Russian Federation, Moscow
A. P. Lykov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Russian Federation, Moscow; Novosibirsk
O. V. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Russian Federation, Moscow; Novosibirsk
A. F. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Russian Federation, Moscow; Novosibirsk
E. A. Pokushalov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Russian Federation, Novosibirsk
A. B. Romanov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Russian Federation, Novosibirsk
V. I. Konenkov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Russian Federation, Moscow; Novosibirsk
